MX2009013054A - Composicion farmaceutica que comprende un sustrato y un revestimiento que contiene un ingrediente activo y alcohol polivinilico. - Google Patents

Composicion farmaceutica que comprende un sustrato y un revestimiento que contiene un ingrediente activo y alcohol polivinilico.

Info

Publication number
MX2009013054A
MX2009013054A MX2009013054A MX2009013054A MX2009013054A MX 2009013054 A MX2009013054 A MX 2009013054A MX 2009013054 A MX2009013054 A MX 2009013054A MX 2009013054 A MX2009013054 A MX 2009013054A MX 2009013054 A MX2009013054 A MX 2009013054A
Authority
MX
Mexico
Prior art keywords
substrate
polyvinylalcohol
pharmaceutical composition
active ingredient
coating containing
Prior art date
Application number
MX2009013054A
Other languages
English (en)
Inventor
Joseph P Reo
Mohammed A Kabir
Glenn E Fritz
Original Assignee
Schering Plough Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Healthcare filed Critical Schering Plough Healthcare
Publication of MX2009013054A publication Critical patent/MX2009013054A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composiciones de materia que contienen un agente activo, y métodos de fabricación de las mismas, en donde el método comprende el paso de revestir un sustrato con una composición de revestimiento que comprende el agente activo formulado para liberación inmediata, en donde la composición de revestimiento no contiene una cantidad apreciable de materiales celulósicos y preferiblemente comprende alcohol polivinílico o un copolímero derivado de alcohol polivinílico.
MX2009013054A 2007-06-01 2008-05-30 Composicion farmaceutica que comprende un sustrato y un revestimiento que contiene un ingrediente activo y alcohol polivinilico. MX2009013054A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94157707P 2007-06-01 2007-06-01
PCT/US2008/006914 WO2008150493A1 (en) 2007-06-01 2008-05-30 Pharmaceutical composition comprising a substrate and a coating containing an active ingredient and polyvinylalcohol

Publications (1)

Publication Number Publication Date
MX2009013054A true MX2009013054A (es) 2010-01-15

Family

ID=39768532

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009013054A MX2009013054A (es) 2007-06-01 2008-05-30 Composicion farmaceutica que comprende un sustrato y un revestimiento que contiene un ingrediente activo y alcohol polivinilico.

Country Status (8)

Country Link
US (1) US20080299186A1 (es)
EP (1) EP2164472A1 (es)
CN (1) CN101848706A (es)
BR (1) BRPI0812784A2 (es)
CA (1) CA2697959A1 (es)
MX (1) MX2009013054A (es)
RU (1) RU2009148862A (es)
WO (1) WO2008150493A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2210595A1 (en) 2009-01-14 2010-07-28 LEK Pharmaceuticals d.d. Active coating of pharmaceutical dosage forms
WO2012031124A2 (en) * 2010-09-03 2012-03-08 Bristol-Myers Squibb Company Drug formulations using water soluble antioxidants
CN104914096B (zh) * 2015-05-07 2018-02-16 西北农林科技大学 一种克伦特罗检测工作液及检测方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2993836A (en) * 1958-02-20 1961-07-25 Dow Chemical Co Sustained release tablets
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US5025019A (en) * 1984-04-09 1991-06-18 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
US5085865A (en) * 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
CA2087435C (en) * 1990-08-07 1998-05-05 Scott Max Herbig Use of interfacially-polymerized membranes in delivery devices
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
US6160020A (en) * 1996-12-20 2000-12-12 Mcneill-Ppc, Inc. Alkali metal and alkaline-earth metal salts of acetaminophen
MX9701946A (es) * 1997-03-14 1998-04-30 Arturo Jimenez Bayardo Solucion oftalmica transportadora.
EP1021204B1 (en) * 1997-09-26 2005-12-28 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6602521B1 (en) * 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
US6521254B2 (en) * 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6267986B1 (en) * 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
US6114346A (en) * 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
AU2277101A (en) * 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
SK287105B6 (sk) * 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
WO2001089476A1 (en) * 2000-05-19 2001-11-29 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
AU2002220248A1 (en) * 2000-11-06 2002-05-15 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US20030236275A1 (en) * 2002-06-20 2003-12-25 Schering Corporation Treatment methods of nasal congestion and nasal obstruction
US7163696B2 (en) * 2001-10-11 2007-01-16 Pfizer Inc. Pharmaceutical formulations
US20030083354A1 (en) * 2001-10-26 2003-05-01 Pediamed Pharmaceuticals, Inc. Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions
US20030114535A1 (en) * 2001-12-14 2003-06-19 Jame Fine Chemicals, Inc. Dextrochlorpheniramine tannate
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US6979689B2 (en) * 2002-12-20 2005-12-27 Pediamed Pharmaceuticals, Inc. Compositions and methods for treating upper respiratory congestion
US20040214215A1 (en) * 2003-03-07 2004-10-28 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
US20050152967A1 (en) * 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
US20050026890A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
US20050095288A1 (en) * 2003-11-03 2005-05-05 Andrx Labs, Llc Decongestant and expectorant tablets
US20050266032A1 (en) * 2003-12-17 2005-12-01 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
US9492541B2 (en) * 2004-09-14 2016-11-15 Sovereign Pharmaceuticals, Llc Phenylepherine containing dosage form
MX2007007069A (es) * 2004-12-13 2008-01-30 Johnson & Johnson Composiciones y metodos para estabilizar ingredientes farmaceuticos activos.
US20070014855A1 (en) * 2005-07-12 2007-01-18 Rahul Gawande S Stable desloratadine compositions
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
US8940796B2 (en) * 2006-02-21 2015-01-27 Wyeth Llc Phenylephrine liquid formulations
EP2366381A1 (en) * 2006-06-01 2011-09-21 MSD Consumer Care, Inc. Phenylephrine pharmaceutical formulations and compositions for colonic absorption
US20080014274A1 (en) * 2006-07-14 2008-01-17 Wyeth Enhanced stability phenylephrine liquid compositions
US9005652B2 (en) * 2006-07-25 2015-04-14 Wyeth Chewable tablet containing phenylephrine
US7378082B1 (en) * 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects

Also Published As

Publication number Publication date
CA2697959A1 (en) 2008-12-11
WO2008150493A1 (en) 2008-12-11
BRPI0812784A2 (pt) 2014-12-02
EP2164472A1 (en) 2010-03-24
RU2009148862A (ru) 2011-07-20
CN101848706A (zh) 2010-09-29
US20080299186A1 (en) 2008-12-04

Similar Documents

Publication Publication Date Title
WO2008063910A3 (en) Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions
WO2011084593A3 (en) Abuse-resistant formulations
WO2010064126A3 (en) Controlled release dosage forms
WO2007149801A3 (en) Enteric coated particles containing an active ingredient
WO2009146034A3 (en) Mapk/erk kinase inhibitors and methods of use thereof
WO2007117995A3 (en) Kinase inhibitors
WO2008085570A3 (en) Flux formulations
WO2006044687A3 (en) Kinase inhibitors
TN2009000249A1 (en) Mapk/erk kinase inhibitors
WO2006127067A3 (en) A delivery system for coated active components as part of an edible composition
PT2040755E (pt) Combinação de um inibidor de colinesterase e um composto com afinidade para o receptor 5-ht6
WO2008115890A3 (en) Mapk/erk kinase inhibitors
EP1928431B8 (en) Controlled release pharmaceutical composition containing carvedilol
WO2009154810A3 (en) Delivery systems for multiple active agents
MX2010002908A (es) Composiciones recubiertas por inmersion que contienen copolimeros de alcohol polivinilico y polietilenglicol y una goma.
WO2007099171A3 (en) Bicyclo-pyrazoles active as kinase inhibitors
MX2009004269A (es) Inhibidores de cinasa mapk/erk.
MX2009013054A (es) Composicion farmaceutica que comprende un sustrato y un revestimiento que contiene un ingrediente activo y alcohol polivinilico.
MX2012004316A (es) Agente de recubrimiento de pelicula para la preparacion de solidos y preparacion de solidos utilizando el mismo.
CY1111059T1 (el) Φωτοσταθερη φαρμακευτικη συνθεση η οποια περιεχει βριβουδινη για την αγωγη της ερπητικης κερατιτιδας
WO2004062552A3 (en) Pharmaceutical composition containing a nsaid and a benzimidazole derivative
MX2009004960A (es) Revestimientos de azucar y metodos para los mismos.
WO2009053576A3 (fr) Composition d'enrobage comprenant du polydextrose, procede pour sa preparation et utilisation pour enrober les formes solides ingerables
WO2010018175A3 (en) Oral pharmaceutical formulation for omeprazole comprising a specific separation layer
UA102680C2 (ru) Единичная дозированная форма, которая включает привитый сополимер поливинилового спирта-полиэтиленгликоля и стероидный эстроген

Legal Events

Date Code Title Description
HC Change of company name or juridical status

Owner name: MICROSOFT TECHNOLOGY LICENSING, LLC

FA Abandonment or withdrawal